Latest News for: idiopathic

Edit

Alkermes Announces Initiation of Vibrance-3 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Idiopathic Hypersomnia

PR Newswire 01 Apr 2025
ALKS) today announced the initiation of Vibrance-3, a phase 2 clinical study evaluating the safety and efficacy of ALKS 2680 compared to placebo in adults with idiopathic hypersomnia (IH) ... Idiopathic Hypersomnia and Other Hypersomnia Syndromes.
  • 1
×